Last updated on April 2018

Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults


Brief description of study

The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor

Detailed Study Description

Appropriate candidates will receive a CI532 cochlear implant and be fit with the CP1000 sound processor. Imaging will be completed pre-op, intra-op, and post-op to assess implant location. Speech perception testing as well as subjective questionnaires will be administered over 12 months.

Clinical Study Identifier: NCT03007472

Contact Investigators or Research Sites near you

Start Over

Charles Limb, MD

University of California, San Francisco
San Francisco, CA United States

David Kelsall, MD

Rocky Mountain Ear Center
Englewood, CO United States

Bruce Gantz, MD

University of Iowa
Iowa City, IA United States

Teresa Zwolan, PhD

University of Michigan
Ann Arbor, MI United States

Jacques Herzog, MD

The Center for Hearing and Balance Disorders
Chesterfield, MO United States

Robert Cullen, MD

Midwest Ear Institute
Kansas City, MO United States

Craig Buchman, MD

Washington University
Saint Louis, MO United States

Susan Waltzman, PhD

New York University
New York, NY United States

Oliver Adunka, MD

The Ohio State University
Columbus, OH United States

Mark Wood, MD

Hearts for Hearing
Oklahoma City, OK United States

Robert Peters, MD

Dallas Ear Institute
Dallas, TX United States

Brian Perry, MD

Ear Medical Group
San Antonio, TX United States

Neil Giddings, MD

Spokane ENT
Spokane, WA United States